275 related articles for article (PubMed ID: 23235992)
1. A case of pulmonary veno-occlusive disease: diagnostic dilemmas and therapeutic challenges.
Sourla E; Paspala A; Boutou A; Kontou P; Stanopoulos I; Pitsiou G
Ther Adv Respir Dis; 2013 Apr; 7(2):119-23. PubMed ID: 23235992
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil as adjunct therapy to high-dose epoprostenol in a patient with pulmonary veno-occlusive disease.
Kuroda T; Hirota H; Masaki M; Sugiyama S; Oshima Y; Terai K; Ito A; Yamauchi-Takihara K
Heart Lung Circ; 2006 Apr; 15(2):139-42. PubMed ID: 16574537
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary veno-occlusive disease: a case series and new observations.
Holcomb BW; Loyd JE; Ely EW; Johnson J; Robbins IM
Chest; 2000 Dec; 118(6):1671-9. PubMed ID: 11115457
[TBL] [Abstract][Full Text] [Related]
4. Occlusive venopathy phenotype in hereditary pulmonary arterial hypertension.
Franchi SM; Aiello VD; Lopes AA
Arq Bras Cardiol; 2011 Jul; 97(1):e8-10. PubMed ID: 21894395
[TBL] [Abstract][Full Text] [Related]
5. Lengthy diagnostic challenge in a rare case of pulmonary veno-occlusive disease: case report and review of the literature.
Ye XQ; Yan CS; Zhang XY; Cai Y; Guo F; Kuang JL
Intern Med; 2011; 50(12):1323-7. PubMed ID: 21673470
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology.
Montani D; Achouh L; Dorfmüller P; Le Pavec J; Sztrymf B; Tchérakian C; Rabiller A; Haque R; Sitbon O; Jaïs X; Dartevelle P; Maître S; Capron F; Musset D; Simonneau G; Humbert M
Medicine (Baltimore); 2008 Jul; 87(4):220-233. PubMed ID: 18626305
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary veno-occlusive disease: recent progress and current challenges.
Montani D; O'Callaghan DS; Savale L; Jaïs X; Yaïci A; Maitre S; Dorfmuller P; Sitbon O; Simonneau G; Humbert M
Respir Med; 2010 Jul; 104 Suppl 1():S23-32. PubMed ID: 20456932
[TBL] [Abstract][Full Text] [Related]
8. [Pulmonary veno-occlusive disease - a rare form of pulmonary arterial hypertension].
Halank M; Kolditz M; Langner S; Höffken G
Dtsch Med Wochenschr; 2008 Oct; 133 Suppl 6():S212-4. PubMed ID: 18814100
[TBL] [Abstract][Full Text] [Related]
9. [Clinical characteristics and survival of patients with pulmonary veno-occlusive disease].
Jiang X; Chen FD; He J; Jiang R; Di RM; Zhao QH; Jing ZC
Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Oct; 39(10):896-900. PubMed ID: 22321271
[TBL] [Abstract][Full Text] [Related]
10. Idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: similarities and differences.
Montani D; Kemp K; Dorfmuller P; Sitbon O; Simonneau G; Humbert M
Semin Respir Crit Care Med; 2009 Aug; 30(4):411-20. PubMed ID: 19634080
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary veno-occlusive disease: advances in clinical management and treatments.
Huertas A; Girerd B; Dorfmuller P; O'Callaghan D; Humbert M; Montani D
Expert Rev Respir Med; 2011 Apr; 5(2):217-29; quiz 230-1. PubMed ID: 21510732
[TBL] [Abstract][Full Text] [Related]
12. Clinical prediction score for identifying patients with pulmonary veno-occlusive disease/pulmonary capillary hemangiomatosis.
Ogawa A; Takahashi Y; Matsubara H
J Cardiol; 2018 Sep; 72(3):255-260. PubMed ID: 29548663
[TBL] [Abstract][Full Text] [Related]
13. Lung transplantation as a viable option of treatment for pulmonary veno-occlusive disease.
Ochman M; Urlik M; Tatoj Z; Wajda-Pokrontka M; Zawadzki F; Latos M; Zembala M
Adv Respir Med; 2018; 86(5):249-254. PubMed ID: 30378654
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary veno-occlusive disease presenting with recurrent pulmonary oedema and the use of nitric oxide to predict response to sildenafil.
Creagh-Brown BC; Nicholson AG; Showkathali R; Gibbs JS; Howard LS
Thorax; 2008 Oct; 63(10):933-4. PubMed ID: 18820120
[TBL] [Abstract][Full Text] [Related]
15. Cautious epoprostenol therapy is a safe bridge to lung transplantation in pulmonary veno-occlusive disease.
Montani D; Jaïs X; Price LC; Achouh L; Degano B; Mercier O; Mussot S; Fadel E; Dartevelle P; Sitbon O; Simonneau G; Humbert M
Eur Respir J; 2009 Dec; 34(6):1348-56. PubMed ID: 19541723
[TBL] [Abstract][Full Text] [Related]
16. Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis.
Miura A; Akagi S; Nakamura K; Ohta-Ogo K; Hashimoto K; Nagase S; Kohno K; Kusano K; Ogawa A; Matsubara H; Toyooka S; Oto T; Ohtsuka A; Ohe T; Ito H
Cardiovasc Pathol; 2013; 22(4):287-93. PubMed ID: 23312620
[TBL] [Abstract][Full Text] [Related]
17. Long-term follow-up after conversion from intravenous epoprostenol to oral therapy with bosentan or sildenafil in 13 patients with pulmonary arterial hypertension.
Johnson RF; Loyd JE; Mullican AL; Fink CA; Robbins IM
J Heart Lung Transplant; 2007 Apr; 26(4):363-9. PubMed ID: 17403478
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Veno-occlusive Disease: A Surgical Lung Biopsy-proven and Autopsied Case Radiologically Mimicking Hypersensitivity Pneumonitis at the Time of a Transbronchial Lung Biopsy.
Minomo S; Kitaichi M; Arai T; Matsui H; Akira M; Inoue Y
Intern Med; 2019 Apr; 58(7):955-964. PubMed ID: 30568112
[TBL] [Abstract][Full Text] [Related]
19. Goal-oriented therapy in pulmonary veno-occlusive disease: a word of caution.
Montani D; Jaïs X; Dorfmuller P; Simonneau G; Sitbon O; Humbert M
Eur Respir J; 2009 Nov; 34(5):1204-6. PubMed ID: 19880623
[No Abstract] [Full Text] [Related]
20. [A 24-year-old male patient with pulmonary veno-occlusive disease - case report].
Cwiek E; Przemęcka M; Marczak J; Kuś J; Langfort R; Górski P
Pneumonol Alergol Pol; 2014; 82(3):271-5. PubMed ID: 24793152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]